Pyrazinamide description: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Pyrazinamide }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PYRAZINAMIDE (PYRAZINAMIDE) TABLET [MIK..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Description== | |||
Pyrazinamide, the pyrazine analogue of nicotinamide, is an antituberculous agent. It is a white crystalline powder, stable at room temperature, and sparingly soluble in water. Pyrazinamide has the following structural formula: | |||
{| | |||
|- | |||
| [[File:PYRAZINAMIDE1.jpg|800px|thumb]] | |||
|- | |||
|} | |||
Each Pyrazinamide tablet for oral administration contains 500 mg of pyrazinamide and the following inactive ingredients: dibasic calcium phosphate (dihydrate), colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose, and stearic acid. | |||
Revision as of 00:14, 4 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Description
Pyrazinamide, the pyrazine analogue of nicotinamide, is an antituberculous agent. It is a white crystalline powder, stable at room temperature, and sparingly soluble in water. Pyrazinamide has the following structural formula:
 |
Each Pyrazinamide tablet for oral administration contains 500 mg of pyrazinamide and the following inactive ingredients: dibasic calcium phosphate (dihydrate), colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose, and stearic acid.
References
Adapted from the FDA Package Insert.